Singapore markets closed

Gilead Sciences Inc (GIS.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
61.13-0.17 (-0.28%)
As of 04:06PM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
485,000
5,665,000
4,592,000
6,225,000
123,000
-
Depreciation & amortisation
2,743,000
2,693,000
2,103,000
2,050,000
1,480,000
-
Deferred income taxes
-1,382,000
-962,000
-1,552,000
-116,000
-214,000
-
Stock-based compensation
788,000
766,000
637,000
635,000
643,000
-
Change in working capital
-2,220,000
-2,303,000
-1,763,000
489,000
-1,638,000
-
Accounts receivable
-544,000
157,000
-406,000
313,000
-1,171,000
-
Inventory
-660,000
-842,000
-310,000
11,000
-195,000
-
Accounts payable
-3,000
-347,000
226,000
-118,000
80,000
-
Other working capital
7,900,000
7,421,000
8,344,000
10,805,000
7,518,000
-
Other non-cash items
5,689,000
1,982,000
1,724,000
1,515,000
6,106,000
-
Net cash provided by operating activities
8,481,000
8,006,000
9,072,000
11,384,000
8,168,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-581,000
-585,000
-728,000
-579,000
-650,000
-
Acquisitions, net
-4,644,000
-1,152,000
-1,797,000
-1,584,000
-25,742,000
-
Purchases of investments
-2,374,000
-2,372,000
-1,942,000
-3,897,000
-20,770,000
-
Sales/maturities of investments
3,945,000
1,844,000
2,002,000
2,910,000
32,718,000
-
Other investing activities
-
-
-1,000
19,000
-171,000
-434,000
Net cash used for investing activities
-3,646,000
-2,265,000
-2,466,000
-3,131,000
-14,615,000
-
Cash flows from financing activities
Debt repayment
-
-2,250,000
-1,500,000
-4,750,000
-2,500,000
-
Common stock issued
281,000
232,000
309,000
169,000
256,000
-
Common stock repurchased
-1,000,000
-1,000,000
-1,396,000
-546,000
-1,583,000
-
Dividends paid
-3,830,000
-3,809,000
-3,709,000
-3,605,000
-3,449,000
-
Other financing activities
-261,000
-278,000
-173,000
-145,000
-138,000
-
Net cash used provided by (used for) financing activities
-5,079,000
-5,126,000
-6,469,000
-8,877,000
770,000
-
Net change in cash
-218,000
673,000
74,000
-659,000
-5,634,000
-
Cash at beginning of period
4,936,000
5,412,000
5,338,000
5,997,000
11,631,000
-
Cash at end of period
4,692,000
6,085,000
5,412,000
5,338,000
5,997,000
-
Free cash flow
Operating cash flow
8,481,000
8,006,000
9,072,000
11,384,000
8,168,000
-
Capital expenditure
-581,000
-585,000
-728,000
-579,000
-650,000
-
Free cash flow
7,900,000
7,421,000
8,344,000
10,805,000
7,518,000
-